• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Array BioPharma

Biotech

The AKT is over: Roche dumps phase 3 prostate cancer prospect

The Swiss drug developer has dropped a phase 3 prostate cancer trial—and sent its acute graft-versus-host disease prospect packing at the same time.
Nick Paul Taylor Feb 2, 2023 4:20am

Pfizer drops cardiology drug after phase 3 fails futility check

Aug 4, 2022 9:20am

Treating melanoma by turning off a common mutation

Jan 31, 2019 1:50pm

AstraZeneca’s selumetinib flops in thyroid cancer

Jul 26, 2018 4:27am

Merck's ERK inhibitor shows promise against resistant cancers

Feb 22, 2018 3:57pm

Array’s encorafenib/binimetinib beats Roche’s Zelboraf in phase 3

Feb 6, 2018 10:27am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy